The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider ownership for the SLS is 1.70%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. The Institutional ownership for the SLS is 20.10%.
Institutional transactions is the amount of a SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)’s available stock owned by mutual or pension funds, insurance companies, investment firms, private foundations, endowments or other large entities that actually manage the funds on the behalf of others, so its an interesting element for the traders to note it, and the Institutional ownership for the SLS is -8.89%.
A Healthcare sector firm, SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) stock gained 15.29% on Friday and when day-trade ended the stock finally concluded at $0.23 and number of shares that changed hands during the day are 97.23 Million. The number of shares SLS stock currently held by all its shareholders are 26.55 and floated shares, the number of shares are available for trading in an open market on last trading day are 24.70. The average volume of shares for 3 months is 7932.68 and SLS stock value has moved between $0.1 – 3.83 in last one year.
[finviz ticker=SLS]
The SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)’s latest earnings date is 6/21/2019. The Gross margin is the difference between the revenue and the cost of goods sold (COGS), divided by revenue. In other words, Gross Margin is a percentage value, while Gross Profit is a monetary value. SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) stock has gained -81.11% in 2019 to date.
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)’s monthly stock performance is -56.41%, the quarterly performance is -77.45%, the half year performance is calculated as -83.64%. The yearly performance of SLS is -92.96%.
The higher the volatility, the riskier the security. For example, when the stock market rises and falls more than one percent over a sustained period of time, it is called a “volatile” market, if the stock price stays relatively stable, the security has low volatility. The SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) weekly volatility is measured as 29.44% and monthly volatility measured as 16.93%.
Return on assets (ROA) is a main indicator of how profitable a company is relative to its total assets. SLS return on assets is -141.80%, the return on equity (ROE) of the SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) is -600.20%.
The price to book ratio is 1.79, price to cash per share ration is 2.37. Analysts mean target price for SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) is $8.75 while analysts mean recommendation is 2.00. The current share price indicates that stock is -94.00% away from its one year high and is moving 127.52% ahead of its 52-week low. SLS’s distance from 20 day simple moving average is 0.87% and distance from 50-Day simple moving average is -59.59%.
